MiR-7-5p expression was significantly reduced in ACC and could suppress cell proliferation and contribute to cell cycle arrest by targeting rapidly accelerated fibrosarcoma 1 and mammalian target of rapamycin.[108] Targeted delivery of extracellular vesicles containing miR-7-5p in vitro significantly inhibited ACC growth, indicating the potential of miR-7-5p to be a novel therapy for ACC. Here, MTOR is linked to adrenal cortex carcinoma.